As an antacid for symptomatic relief of hyperacidity associated with the diagnosis of peptic ulcer, gastritis, peptic esophagitis, gastric hyperacidity, or hiatal hernia. In addition, it is an antiflatulent to alleviate the symptoms of gas, including post operative gas pain.
SIDE EFFECTS & PRECAUTIONS:
Prolonged use of aluminium-containing antacids in patients with renal failure may result in or worsen dialysis osteomalacia. Elevated tissue aluminium levels contribute to the development of the dialysis encephalopathy and osteomalacia syndromes. Small amounts of aluminium are absorbed from the gastrointestinal tract and renal excretion of aluminium is impaired in renal failure. Aluminium is not well removed by dialysis because it is bound to albumin and transferrin, which do not cross membranes. As a result, aluminium is deposited in bone, and dialysis osteomalacia may develop when large amounts of aluminium are ingested orally by patients with impaired renal function.
Aluminium forms insoluble complexes with phosphate in the gastrointestinal tract, thus decreasing phosphate absorption. Prolonged use of aluminium-containing antacids by normophosphatemic patients may result in hypophosphatemia if phosphate intake is not adequate because Aluminium forms insoluble complexes with phosphate in the gastrointestinal tract. In its more severe forms, hypophosphatemia can lead to anorexia, malaise, muscle weakness, and osteomalacia.
DOSAGE & ADMINISTRATION:
Children under 12 years: consult a physician.
Adults/children 12 years and older: take 2 to 4 teaspoons four times a day or as directed by the physician.
Do not take more than 16 teaspoons of BARKALOX PLUS 200 suspension in 24 hours or use the maximum dosage for more than 2 weeks.
Do not take more than 12 teaspoons of BARKALOX PLUS 400 suspension in 24 hours or use the maximum dosage for more than 2 weeks.
Stop use and ask a doctor if symptoms last for more than 2 weeks.
H.D.P.E. bottles of 100 ml or 200 ml.